Information  X 
Enter a valid email address

Valereum Blockchain (VLRM)


Thursday 20 January, 2022

Valereum Blockchain

Results of EGM

RNS Number : 1380Z
Valereum Blockchain PLC
20 January 2022

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (“MAR”)

20 January 2022

Valereum Plc

("Valereum" or the "Company")


Results of Extraordinary General Meeting (EGM)

At the Company's EGM held earlier today shareholders of Valereum Blockchain Plc voted unanimously in favour of the resolution to change the Company's name to Valereum Plc.  

Pursuant to the name change, which is effective from 20 January 2022, the Company has changed its website to This further emphasises the Company's ties to Gibraltar. Also, the Company's Twitter handle has been changed to @ValereumPLC. Valereum's ticker symbol on the Aquis Stock Exchange remains the same, VLRM.

The Directors of the Company accept responsibility for the contents of this announcement.




Valereum Plc

Richard Poulden, Chairman

Tel: +971 4584 6284


AQSE Corporate Adviser

Peterhouse Capital Limited

Mark Anwyl

Tel: +44 (0) 207 469 0930


Investor Relations

J&H Communications Limited

James Henderson

Tel: +44 (0)7774 444163

[email protected]


George Hudson

Tel: +44 (0)7803 603130

[email protected]



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t